purB and ctr mutants of Escherichia coli are resistant to low levels of nalidixic acid.
(AMP).
Mating experiments showed that the gene conferring adenine independence was transferred from HfrH to an Ade-recipient at approximately the same time as a purB+ gene was transferred from the same male into a purB recipient (strain 2, Table 1 ). The Ade+ recombinants were Nalsensitive (Nals) as were all Ade+ derivatives obtained by transduction or reversion. Three other Ade-Nalr mutations were found to map in this region also. These results show that the mutations are not in the purA gene (which maps at 81 min), but are probably in the purB gene [at 23 min (7) ].
No gene other than purA and purB has been reported in which mutation leads to a specific adenine requirement.
A bona fide purB mutant (strain 2) was resistant to Nal, but derivatives transduced to pur+ were Nal' (Fig. IA) . Two Ade-mutations obtained independently by using the penicillin procedure were mapped in the purB region, and the mutants were subsequently found to be Nalr.
Other purine-requiring strains were tested for resistance to Nal, and it was found that all mutants responding to purines other than adenine were sensitive to the drug (Fig. 1) . A purA mutant, strain 6 (which specifically requires adenine for growth), was shown to be sensitive also (Fig.  1B) .
Thus, resistance appears to result from mutation in the purB gene and not from mutation in other genes affecting purine synthesis. purB is probably a structural gene for adenylosuccinase (4) . This enzyme catalyzes two steps in purine synthesis, one step in the main pathway to IMP, the other on the path to AMP (Fig. 2) .
In the purB mutants, Nal resistance is probably due to accumulation of an adenine precursor prior to the block, or to altered function of adenylosuccinase. Although most Ade-Nalr mutants revert, some do not. Presumably the latter contain deletions or other multiple-site mutations, suggesting that resistance stems from complete loss of function and accumulation of an intermediate.
The immediate precursors accumulating in purB mutants are 5-aminoimidazol-4-carboxamide ribonucleotide (SAICAR) and adenylosuccinic acid (ASA) [which is formed by conversion from adenine added to the medium (4)]. purA mutants are Nal' (Fig. 1) , so resistance cannot result from the accumulation of IMP (see Fig. 2 ). It is unlikely that Nal resistance results from the accumulation of intermediates prior to SAICAR, because no Nalr auxotrophs with blocks prior to SAICAR formation were obtained (i.e., no resistant mutants that responded to guanine as well as to adenine). We attempted to test the hypothesis that ASA is the compound giving resistance by trying to block ASA formation in a purB strain with hadacidin, an inhibitor of adenylosuccinate synthetase (6). Although the purB mutant became more sensitive to Nal in the presence of hadacidin, the effect was slight and the hadacidin concentration was large (1 mg/ml); therefore the results were inconclusive. A defini- (-,A) . B, strain 6 and 6purA+ (0,0); strain 7 (purH) (A). C, strain 3 (0); 3 ctr+ (A); 3 ctr+ purF+ (0). Survival of strain I (also purF) is similar to that ofstrain 7, but, for clarity, it is not shown. tive result could be obtained by constructing a double mutant purA purB strain and checking to see whether this is Nalr or Nats.
In the course of these experiments, we identified another class of mutation giving resistance to Nal. A purF strain (strain 3) was resistant to the drug (Fig. 1C) . This strain fails to grow on most carbohydrates. As a result of a ctr mutation, it lacks active transport of many carbohydrates. The loss of active transport appears to be secondary to some more fundamental defect possibly related to catabolite repression (8, 9) . Transductants to ctr+ simultaneously became Nals, and further transduction to pur+ did not alter their sensitivity (Fig. 1C) . Some spontaneous ctr+ revertants (selected for growth on glucose) became Nal' while others remained Nalr. This behavior is in accord with the different patterns of utilization of carbohydrates reported among partial revertants of ctr (8, 9) .
